Physician profile
Indranil Debnath
NPI 1649488735
$109,280.07
in general payments reported to CMS, 2019-2025
17 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $14K · 2021: $11K · 2022: $36K · 2023: $20K · 2024: $14K · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Consulting Fee: $8,400 · Travel and Lodging: $2,724 · Food and Beverage: $2,699 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,285.00 |
| Consulting Fee | $8,400.00 |
| Travel and Lodging | $2,724.05 |
| Food and Beverage | $2,699.31 |
| Education | $122.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $66,995.25 | 2019-2025 | Scopis Ent, Tgs Guidewire, Xpress Ent Dilation System |
| Optinose US, INC. | $40,570.67 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $515.81 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $230.96 | 2019-2025 | |
| Acclarent, INC | $221.81 | 2019-2023 | Trudi Nav Cable |
| Genzyme Corporation | $190.60 | 2019-2025 | |
| Genentech USA, INC. | $125.00 | 2019 | |
| Bard Access Systems, INC. | $94.02 | 2019 | |
| Integra Lifesciences Corporation | $78.78 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Advanced Bionics, LLC | $73.74 | 2020 | |
| Inspire Medical Systems, INC. | $57.76 | 2023-2024 | Inspire |
| Alk-Abello, INC | $30.46 | 2019 | |
| Intersect Ent, INC. | $25.64 | 2020 | |
| Ethicon US, LLC | $22.48 | 2025 | Ethicon |
| Glaxosmithkline, LLC. | $22.35 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.09 | 2019 | |
| Kaleo, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indranil Debnath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.